Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 11 to 14 of 14

Publication Record

Connections

The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2.
Albertini MR, Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Bechhofer R, Storer B, Sondel PM
(1990) Cancer 66: 2457-64
MeSH Terms: Adult, Aged, Blood Transfusion, Autologous, Carcinoma, Renal Cell, Combined Modality Therapy, Female, Hodgkin Disease, Humans, Immunotherapy, Adoptive, Infusions, Parenteral, Interleukin-2, Kidney Neoplasms, Killer Cells, Lymphokine-Activated, Male, Melanoma, Middle Aged, Neoplasms, Recombinant Proteins
Added March 5, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2.
Hank JA, Sosman JA, Kohler PC, Bechhofer R, Storer B, Sondel PM
(1990) J Biol Response Mod 9: 5-14
MeSH Terms: Cell Division, Cells, Cultured, Clinical Trials as Topic, Cytotoxicity Tests, Immunologic, Humans, Interleukin-2, Isoantigens, Killer Cells, Lymphokine-Activated, Lymphocyte Activation, Neoplasms, Phytohemagglutinins, Recombinant Proteins, T-Lymphocytes
Added March 5, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.
Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Goldstein D, Bechhofer R, Storer B, Albertini MR
(1991) Cancer Invest 9: 35-48
MeSH Terms: Adult, Aged, Carcinoma, Renal Cell, Cytotoxicity, Immunologic, Drug Administration Schedule, Female, Humans, Hypotension, Interleukin-2, Kidney Neoplasms, Killer Cells, Lymphokine-Activated, Killer Cells, Natural, Leukocytosis, Male, Middle Aged, Pilot Projects, Recombinant Proteins
Added March 5, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms
Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM
(1990) Cancer Res 50: 2683-91
MeSH Terms: Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, CD3 Complex, CD56 Antigen, Dose-Response Relationship, Drug, Humans, Interleukin-2, Killer Cells, Lymphokine-Activated, Lymphocyte Activation, Phenotype, Receptors, Antigen, T-Cell, Receptors, Interleukin-2
Added March 5, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms